142 related articles for article (PubMed ID: 25649936)
1. Cytotoxic effects of loperamide hydrochloride on canine cancer cells.
Regan RC; Gogal RM; Barber JP; Tuckfield RC; Howerth EW; Lawrence JA
J Vet Med Sci; 2014 Dec; 76(12):1563-8. PubMed ID: 25649936
[TBL] [Abstract][Full Text] [Related]
2. Loperamide, an antidiarrhea drug, has antitumor activity by inducing cell apoptosis.
Gong XW; Xu YH; Chen XL; Wang YX
Pharmacol Res; 2012 Mar; 65(3):372-8. PubMed ID: 22119769
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma.
Roncuzzi L; Perut F; Baldini N
Anticancer Res; 2024 Mar; 44(3):1063-1070. PubMed ID: 38423641
[TBL] [Abstract][Full Text] [Related]
5. Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study.
Elia SG; Al-Karmalawy AA; Nasr MY; Elshal MF
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22938. PubMed ID: 34719826
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
[TBL] [Abstract][Full Text] [Related]
7. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of SB injection in canine osteosarcoma and melanoma cell lines.
Kweon K; Ahn JO; Song WJ; Li Q; Lee BY; Chae HK; Youn HY
In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):7-16. PubMed ID: 30382494
[TBL] [Abstract][Full Text] [Related]
9. Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells.
Yoshida A; Tokuyama S; Iwamura T; Ueda H
Int J Mol Med; 2000 Sep; 6(3):329-35. PubMed ID: 10934299
[TBL] [Abstract][Full Text] [Related]
10. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.
Fouad MA; Sayed-Ahmed MM; Huwait EA; Hafez HF; Osman AM
BMC Pharmacol Toxicol; 2021 Jan; 22(1):8. PubMed ID: 33509300
[TBL] [Abstract][Full Text] [Related]
12. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
13. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
14. The second-generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells.
Kelly B; Thamm D; Rosengren RJ
Vet Comp Oncol; 2023 Dec; 21(4):595-604. PubMed ID: 37435770
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
16. p-Phenylenediamine induces p53-mediated apoptosis in Mardin-Darby canine kidney cells.
Chen SC; Chen CH; Chern CL; Hsu LS; Huang YC; Chung KT; Chye SM
Toxicol In Vitro; 2006 Sep; 20(6):801-7. PubMed ID: 16469477
[TBL] [Abstract][Full Text] [Related]
17. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
18. Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.
Kim IY; Shim MJ; Lee DM; Lee AR; Kim MA; Yoon MJ; Kwon MR; Lee HI; Seo MJ; Choi YW; Choi KS
Biochem Pharmacol; 2019 Apr; 162():41-54. PubMed ID: 30529689
[TBL] [Abstract][Full Text] [Related]
19. Lack of cell-cycle specific effects of tumor necrosis factor-alpha on tumor cells in vitro: implications for combination tumor therapy with doxorubicin.
van der Veen AH; ten Hagen TL; Seynhaeve AL; Eggermont AM
Cancer Invest; 2002; 20(4):499-508. PubMed ID: 12094545
[TBL] [Abstract][Full Text] [Related]
20. Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.
Zhao J; Li R; Pawlak A; Henklewska M; Sysak A; Wen L; Yi JE; Obmińska-Mrukowicz B
In Vivo; 2018; 32(5):1081-1088. PubMed ID: 30150429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
